Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Mobic
Active Ingredient: Meloxicam 7.5mg
Dosage Form: Pale yellow, round uncoated tablet
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
Product: Nuelin-SR
Active Ingredient: Theophylline, anhydrous 125mg
Dosage Form: Modified release tablet
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: 3M Pharmaceuticals Pty Limited, Thornleigh, New South Wales, Australia
Product: Nuelin-SR
Active Ingredient: Theophylline, anhydrous 250mg
Dosage Form: Modified release tablet
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: 3M Pharmaceuticals Pty Limited, Thornleigh, New South Wales, Australia
Product: Nuelin-SR
Active Ingredient: Theophylline, anhydrous 350mg
Dosage Form: Modified release tablet
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: 3M Pharmaceuticals Pty Limited, Thornleigh, New South Wales, Australia
Product: Nuelin-SR
Active Ingredient: Theophylline, anhydrous 500mg
Dosage Form: Modified release tablet
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: 3M Pharmaceuticals Pty Limited, Thornleigh, New South Wales, Australia
Dated this 1st day of February 2006.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).